These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 24770591

  • 1. A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting.
    Wang XF, Feng Y, Chen Y, Gao BL, Han BH.
    Sci Rep; 2014 Apr 28; 4():4813. PubMed ID: 24770591
    [Abstract] [Full Text] [Related]

  • 2. Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.
    Hocking CM, Kichenadasse G.
    Support Care Cancer; 2014 Apr 28; 22(4):1143-51. PubMed ID: 24522741
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis.
    Yoodee J, Permsuwan U, Nimworapan M.
    Crit Rev Oncol Hematol; 2017 Apr 28; 112():113-125. PubMed ID: 28325253
    [Abstract] [Full Text] [Related]

  • 4. Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
    Bosnjak SM, Dimitrijevic J, Djordjevic F.
    Curr Opin Support Palliat Care; 2016 Jun 28; 10(2):180-8. PubMed ID: 27028050
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis.
    Yokoe T, Hayashida T, Nagayama A, Nakashoji A, Maeda H, Seki T, Takahashi M, Takano T, Abe T, Kitagawa Y.
    Oncologist; 2019 Jun 28; 24(6):e347-e357. PubMed ID: 30333194
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review.
    Chow R, Chiu L, Navari R, Passik S, Chiu N, Popovic M, Lam H, Pasetka M, Chow E, DeAngelis C.
    Support Care Cancer; 2016 Feb 28; 24(2):1001-1008. PubMed ID: 26530228
    [Abstract] [Full Text] [Related]

  • 8. Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting.
    DeRemer DL, Clemmons AB, Orr J, Clark SM, Gandhi AS.
    Pharmacotherapy; 2016 Feb 28; 36(2):218-29. PubMed ID: 26890915
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemotherapy-induced nausea and vomiting.
    Lohr L.
    Cancer J; 2008 Feb 28; 14(2):85-93. PubMed ID: 18391612
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Olanzapine for preventing nausea and vomiting induced by moderately and highly emetogenic chemotherapy.
    Wang SY, Yang ZJ, Zhang L.
    Asian Pac J Cancer Prev; 2014 Feb 28; 15(22):9587-92. PubMed ID: 25520071
    [Abstract] [Full Text] [Related]

  • 14. Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting.
    Tan L, Liu J, Liu X, Chen J, Yan Z, Yang H, Zhang D.
    J Exp Clin Cancer Res; 2009 Sep 23; 28(1):131. PubMed ID: 19775450
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for managing highly emetogenic chemotherapy in Southeast Asia: a multinational study.
    Chanthawong S, Lim YH, Subongkot S, Chan A, Andalusia R, Ahmad Bustamam RS, Chaiyakunapruk N.
    Support Care Cancer; 2019 Mar 23; 27(3):1109-1119. PubMed ID: 30112718
    [Abstract] [Full Text] [Related]

  • 16. QoL evaluation of olanzapine for chemotherapy-induced nausea and vomiting comparing with 5-HT3 receptor antagonist.
    Liu J, Tan L, Zhang H, Li H, Liu X, Yan Z, Chen J, Yang H, Zhang D.
    Eur J Cancer Care (Engl); 2015 May 23; 24(3):436-43. PubMed ID: 25404537
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
    Hilarius DL, Kloeg PH, van der Wall E, van den Heuvel JJ, Gundy CM, Aaronson NK.
    Support Care Cancer; 2012 Jan 23; 20(1):107-17. PubMed ID: 21258948
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting: a meta-analysis.
    Yang T, Liu Q, Lu M, Ma L, Zhou Y, Cui Y.
    Br J Clin Pharmacol; 2017 Jul 23; 83(7):1369-1379. PubMed ID: 28112422
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: a Bayesian network meta-analysis.
    Alhifany AA, McBride A, Almutairi AR, Cheema E, Shahbar A, Alatawi Y, Alharbi AS, Babiker H, MacDonald K, Aapro M, Abraham I.
    Support Care Cancer; 2020 Mar 23; 28(3):1031-1039. PubMed ID: 31823054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.